Watch More! Unlock the full videos with a FREE trial
Add to Study plan
Master
Included In This Lesson
Access More! View the full outline and transcript with a FREE trial
Outline
What is the generic name?
MOXETUMOMAB PASUDOTOX
What is the Trade Name for MOXETUMOMAB PASUDOTOX?
LUMOXITI
What are the Indications for MOXETUMOMAB PASUDOTOX?
- 1 INDICATIONS AND USAGE LUMOXITI is indicated for the treatment of adult patients with relapsed or refractory hairy cell leukemia (HCL) who received at least two prior systemic therapies, including treatment with a purine nucleoside analog (PNA). Limitations of Use LUMOXITI is not recommended in patients with severe renal impairment (CrCl ≤ 29 mL/min) [see Dosage and Administration (2.3) , Warnings and Precautions (5.3) , and Use in Specific Populations (8.5) ] . LUMOXITI is a CD22-directed cytotoxin indicated for the treatment of adult patients with relapsed or refractory hairy cell leukemia (HCL) who received at least two prior systemic therapies, including treatment with a purine nucleoside analog (PNA). (1) Limitations of Use Not recommended in patients with severe renal impairment (CrCl ≤ 29 mL/min). (1)
View Our Nursing Pharmacology Course
References: https://open.fda.gov/
Other Pharm Resources
View the FULL Outline
When you start a FREE trial you gain access to the full outline as well as:
- SIMCLEX (NCLEX Simulator)
- 6,500+ Practice NCLEX Questions
- 2,000+ HD Videos
- 300+ Nursing Cheatsheets
“Would suggest to all nursing students . . . Guaranteed to ease the stress!”
~Jordan